IPO registrations (S-1, F-1) · Registrants
PROKIDNEY CORP.
- SEC CIK
- 1850270 · filings on EDGAR ↗
- Former names
- Social Capital Suvretta Holdings Corp. III (2021–2022)
- Registration
- Form S-1, first filed 2021-06-02, last 2022-08-26; 2 initial registrations, 3 amendments
- Outcome
- Final prospectus filed 2021-07-01; declared effective 2021-06-29
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- E9
- Business address
- 2000 FRONTIS PLAZA BLVD., SUITE 250, Winston-Salem, NC 27103
- EIN
- 98-1586514
- Ticker
- PROK (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- PROKIDNEY CORP. on the corporate pages
Offering terms
- Final price
- $10.00 per share (424B4 filed 2021-07-01, an initial public offering)
- Shares sold
- 22,000,000
- Gross proceeds
- $220,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol DNAC
- Lead underwriters
- Morgan Stanley
- Syndicate
- SoFi Securities, LLC (2,200,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: ProKidney, LLC Fuzzy (name and state)
- Business registration: ProKidney, LLC Fuzzy (name and state)
- Business registration: PROKIDNEY, LLC Fuzzy (name and state)
- Business registration: PROKIDNEY, LLC Fuzzy (name and state)
- Business registration: PROKIDNEY, LLC Fuzzy (name and state)
- Business registration: PROKIDNEY, LLC Fuzzy (name and state)
- Lobbying client: PROKIDNEY Fuzzy (name and state)
- SEC filer: PROKIDNEY CORP. EXACT (CIK (EXACT))
- Person page: Pablo G Legorreta Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,TenPercentOwner))
Filings 12
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2021-06-02 | S-1 | S-1 (registration) | Social Capital Suvretta Holdings Corp. III | 0001193125-21-180036 ↗ |
| 2021-06-09 | S-1/A | S-1/A (amendment) | Social Capital Suvretta Holdings Corp. III | 0001193125-21-185878 ↗ |
| 2021-06-25 | S-1/A | S-1/A (amendment) | Social Capital Suvretta Holdings Corp. III | 0001193125-21-200628 ↗ |
| 2021-06-29 | EFFECT | EFFECT (declared effective) | Social Capital Suvretta Holdings Corp. III | 9999999995-21-002571 ↗ |
| 2021-06-30 | S-1MEF | S-1MEF (added securities) | Social Capital Suvretta Holdings Corp. III | 0001193125-21-204042 ↗ |
| 2021-07-01 | 424B4 | 424B4 (final prospectus) | Social Capital Suvretta Holdings Corp. III | 0001193125-21-206538 ↗ |
| 2022-08-09 | S-1 | S-1 (registration) | PROKIDNEY CORP. | 0001193125-22-215250 ↗ |
| 2022-08-26 | S-1/A | S-1/A (amendment) | PROKIDNEY CORP. | 0001193125-22-231275 ↗ |
| 2022-09-08 | EFFECT | EFFECT (declared effective) | PROKIDNEY CORP. | 9999999995-22-002632 ↗ |
| 2023-04-20 | EFFECT | EFFECT (declared effective) | PROKIDNEY CORP. | 9999999995-23-000990 ↗ |
| 2023-08-21 | EFFECT | EFFECT (declared effective) | PROKIDNEY CORP. | 9999999995-23-002451 ↗ |
| 2023-11-30 | EFFECT | EFFECT (declared effective) | PROKIDNEY CORP. | 9999999995-23-003507 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-06-25 | S-1/A | registration statement | $10.00 | 20,000,000 | $200,000,000 | Nasdaq DNAC | 1 | primary document; price sentence, shares headline, proceeds table, cover names 1 | document ↗ | |
| 2021-07-01 | 424B4 | final prospectus | $10.00 | 22,000,000 | $220,000,000 | Nasdaq DNAC | 2 | primary document; price sentence, shares headline, proceeds table, underwriting table 1, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| ChaChaCha DNA III, LLC | Director,TenPercentOwner; Other | 4 | 2021–2022 | ||
| Cowen Aaron | Other; TenPercentOwner | 10 | 2021–2025 | ||
| Katz Shoney | Officer | Director of Research | 1 | 2021 | |
| Mehta Kishan | Director,Officer,TenPercentOwner; Other | 4 | 2021–2022 | ||
| Palihapitiya Chamath | Director,Officer,TenPercentOwner; Other; TenPercentOwner | President | 17 | 2021–2023 | |
| Ryans James | Officer | Chief Financial Officer | 1 | 2021 | |
| SCS Sponsor III LLC | Director,TenPercentOwner; Other | Chief Executive Officer | 4 | 2021–2022 | |
| Semigran Marc | Director | 1 | 2021 | ||
| Sinha Uma | Director | 6 | 2021–2026 | ||
| Bertram Timothy | Director,Officer | Chief Executive Officer | 4 | 2022–2023 | |
| Control Empresarial de Capitales S.A. de C.V. | TenPercentOwner; TenPercentOwner,Other | 10 | 2022–2026 | ||
| Coulston James | Officer | Chief Financial Officer | 7 | 2022–2026 | |
| DOYLE WILLIAM F | Director | 6 | 2022–2026 | ||
| Fox Jennifer A. | Director | 7 | 2022–2026 | ||
| Girolamo Todd C | Officer | Chief Legal Officer | 10 | 2022–2026 | |
| Jain Deepak | Officer | Chief Operating Officer | 4 | 2022–2023 | |
| Jimenez Santos Jose Ignacio | Director | 5 | 2022–2026 | ||
| Legorreta Pablo G. | Director; Director,TenPercentOwner | 11 | 2022–2026 | person page Fuzzy | |
| Lotvin Alan | Director | 6 | 2022–2026 | ||
| MARAGANORE JOHN | Director | 3 | 2022–2023 | ||
| McKenzie Libbie Parker | Officer | Chief Medical Officer | 4 | 2022–2023 | |
| Pereira Brian JG | Director | 10 | 2022–2026 | ||
| Tolerantia, LLC | TenPercentOwner | 7 | 2022–2025 | ||
| Weber Darin J. | Officer | Chief Regulatory Officer; SVP of Regulatory Development | 17 | 2022–2026 | |
| SC Master Holdings, LLC | Other; TenPercentOwner | 13 | 2022–2023 | ||
| SC PIPE Holdings LLC | TenPercentOwner | 9 | 2022–2023 | ||
| Weger Mary | Officer | Chief People Officer | 3 | 2023 | |
| Culleton Bruce | Director,Officer; Officer | Chief Executive Officer; EVP, Clinical Development | 6 | 2023–2026 | |
| Ernst Ulrich Peter Alfred | Officer | EVP, Technical Operations | 2 | 2024 | |
| Locke Kenneth Thomas | Officer | Chief Technical Officer | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | ProKidney, LLC | NC | State business registries | name and state |
| Business registration | ProKidney, LLC | NC | State business registries | name and state |
| Business registration | PROKIDNEY, LLC | NC | State business registries | name and state |
| Business registration | PROKIDNEY, LLC | NC | State business registries | name and state |
| Business registration | PROKIDNEY, LLC | NC | State business registries | name and state |
| Business registration | PROKIDNEY, LLC | NC | State business registries | name and state |
| Plan sponsor | PROKIDNEY, LLC | NC | Form 5500 (employee benefit plans) | name and state |
| Lobbying client | PROKIDNEY | NC | Federal lobbying (LDA) | name and state |
| SEC filer | PROKIDNEY CORP. | SEC filers (EDGAR) | CIK (EXACT) | |
| Person page | Pablo G Legorreta | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,TenPercentOwner) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), NC first:
- ALDAGEN INC NC
- FENNEC PHARMACEUTICALS INC. NC
- TENGION INC NC
- Chelsea Therapeutics International, Ltd. NC
- AERIE PHARMACEUTICALS INC NC
- PRECISION BIOSCIENCES INC NC
- Axium Pharmaceuticals Inc. NC
- Immunovant, Inc. NC
- Humacyte, Inc. NC
- Pelthos Therapeutics Inc. NC
In other datasets, the same topic (Health) in NC:
- Nonprofit: 24 FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health